01221nas a2200481   4500000000100000008004100001260001300042653001500055653001100070653003100081653002000112653001600132653002600148653000900174653001200183653001000195653001500205653002500220653001400245653001200259653003200271653001000303653001400313653002700327653001900354653003000373653001200403653001800415653003200433653002500465653001500490653001500505653003100520653000900551653001700560653001900577653003000596100001800626245006100644300001300705490000700718022001400725       1992                            d  c1992 Jan10aAdolescent10aAfrica10aAfrica South of the Sahara10aAfrica, Western10aAge Factors10aAnti-Bacterial Agents10aAsia10aBiology10aChild10aDemography10aDeveloping countries10adiagnosis10aDisease10aEvaluation Studies as Topic10aIndia10aInfection10aInternational Agencies10aMass Screening10aNeurologic Manifestations10aNigeria10aOrganizations10aPharmaceutical Preparations10aPhysical Examination10aPhysiology10aPopulation10aPopulation Characteristics10aSkin10aTherapeutics10aUnited Nations10aWorld Health Organization1 aMcDougall A C00aLeprosy: an urgent need to step up use of MDT in Africa.  a31, 34-50 v14  a0141-9536